BSEInsider Trading / SAST6 Oct 2026 · 6 Oct 2026, 05:13 pm
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sumeet Dhanraj Garad
iSERA Lifesciences Ltd · 534920
✦ AI SummaryRelated Party
iSERA Lifesciences Ltd has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sumeet Dhanraj Garad, indicating a potential change in control or significant stake acquisition.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern6/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
iSERA Lifesciences Ltd - 534920 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011